# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001493152-21-024612
Filing Date
2021-10-05
Accepted
2021-10-05 15:06:36
Documents
39
Period of Report
2021-10-05
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form8-k.htm iXBRL | 8-K | 38922
2 |  | ex99-1.htm | EX-99.1 | 21599
3 |  | ex99-1_001.jpg | GRAPHIC | 621922
4 |  | ex99-1_002.jpg | GRAPHIC | 790930
5 |  | ex99-1_003.jpg | GRAPHIC | 734559
6 |  | ex99-1_004.jpg | GRAPHIC | 635173
7 |  | ex99-1_005.jpg | GRAPHIC | 892379
8 |  | ex99-1_006.jpg | GRAPHIC | 534102
9 |  | ex99-1_007.jpg | GRAPHIC | 433438
10 |  | ex99-1_008.jpg | GRAPHIC | 852698
11 |  | ex99-1_009.jpg | GRAPHIC | 550734
12 |  | ex99-1_010.jpg | GRAPHIC | 472609
13 |  | ex99-1_011.jpg | GRAPHIC | 498918
14 |  | ex99-1_012.jpg | GRAPHIC | 299223
15 |  | ex99-1_013.jpg | GRAPHIC | 600667
16 |  | ex99-1_014.jpg | GRAPHIC | 511506
17 |  | ex99-1_015.jpg | GRAPHIC | 345563
18 |  | ex99-1_016.jpg | GRAPHIC | 474852
19 |  | ex99-1_017.jpg | GRAPHIC | 686391
20 |  | ex99-1_018.jpg | GRAPHIC | 585540
21 |  | ex99-1_019.jpg | GRAPHIC | 419768
22 |  | ex99-1_020.jpg | GRAPHIC | 474535
23 |  | ex99-1_021.jpg | GRAPHIC | 593380
24 |  | ex99-1_022.jpg | GRAPHIC | 516401
25 |  | ex99-1_023.jpg | GRAPHIC | 558228
26 |  | ex99-1_024.jpg | GRAPHIC | 171926
27 |  | ex99-1_025.jpg | GRAPHIC | 458084
28 |  | ex99-1_026.jpg | GRAPHIC | 537889
| Complete submission text file | 0001493152-21-024612.txt |  | 19857217

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
29 | INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | envb-20211005.xsd | EX-101.SCH | 3022
30 | INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | envb-20211005_lab.xml | EX-101.LAB | 34240
31 | INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | envb-20211005_pre.xml | EX-101.PRE | 22357
32 | EXTRACTED XBRL INSTANCE DOCUMENT | form8-k_htm.xml | XML | 3743

Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38286 | Film No.: 211306345
SIC: 2834 Pharmaceutical Preparations